Matt Roache | executive |
Thomas McCourt | executive |
Michael Shetzline | executive |
Sravan Emany | executive |
Amy Li | analyst |
Mohit Bansal | analyst |
Chase Knickerbocker | analyst |
Jason Butler | analyst |
Timothy Chiang | analyst |
Good day, and welcome to the Ironwood Pharmaceuticals Fourth Quarter and Full Year 2023 Investor Update Call. [Operator Instructions] And finally, I would like to advise all participants that this call is being recorded. Thank you.
I'd now like to welcome Matt Roache, Director of Investor Relations to begin the conference. Matt, over to you.